ATG3 and hepatocellular carcinoma: NEAT promoted autophagy-mediated chemoresistance as a ceRNA targeting the miR-204/ATG3 axis in HCC [70], miR-9-5p/SPAG9 in anaplastic thyroid carcinoma [71], and miR-34a/HMGB1, ATG9A, and ATG4B in colorectal cancers [69].